ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared USA

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?
For weight loss drug leaders, the last two weeks have been nothing short of disastrous for shares. Industry pioneer Novo Nordisk A/S (NYSE: NVO) saw its stock drop nearly 22% on July 29 after lowering its full-year guidance. Then, on Aug. 7, Eli Lilly (NYS
Announcement as on 08 August 2025

Eli Lilly stock is tumbling after trial data from oral weight-loss drug

Announcement as on 07 August 2025

UBS slashes target price on Novo Nordisk, citing compounders, Eli Lilly threat

Announcement as on 05 August 2025

Pharma major Eli Lilly claims its weight loss drug reduces cardiovascular risks in Type 2 diabetes patients
Eli Lilly's Mounjaro demonstrates significant cardiovascular benefits for Type 2 diabetes patients with heart disease, reducing mortality and cardiovascular risks. The SURPASS-CVOT trial revealed Mounjaro's superiority over Trulicity, showing improvements
Announcement as on 31 July 2025

Eli Lilly to roll out diabetes medicine in prefilled pen
Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The KwikPen offers a convenient, once-weekly administration. It contains four fixed doses. This launch intensifies competition with No
Announcement as on 27 June 2025

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 1014.99
  • 12Day Average: 1025.76
  • 20Day Average: 1039.76
  • 50Day Average: 937.28
  • 100Day Average: 835.4
  • 150Day Average: 812.24
  • 200Day Average: 814.12

LLY Indicators & signals

Indicator MACD (12,26,9)

1025.11, 1003.47, 30.46
Indicator MACD is in positive zone

Indicator ADX (14)

16.55, 28.92, 20.71
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 59
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
15 Mon Dec 2025 1062.19 1032.55 to 1065.00 3.38% 1.56 times
12 Fri Dec 2025 1027.51 1003.50 to 1028.90 1.8% 1.1 times
11 Thu Dec 2025 1009.38 987.00 to 1031.56 1.58% 1.52 times
10 Wed Dec 2025 993.64 977.12 to 1003.00 1.16% 1 times
09 Tue Dec 2025 982.22 979.18 to 1012.00 -1.54% 0.86 times
08 Mon Dec 2025 997.59 988.88 to 1014.20 -1.21% 1.03 times
05 Fri Dec 2025 1009.77 1004.00 to 1027.39 -0.47% 0.43 times
04 Thu Dec 2025 1014.49 1007.18 to 1032.63 -1.85% 1.3 times
03 Wed Dec 2025 1033.56 1022.32 to 1051.48 -1.13% 1.16 times
02 Tue Dec 2025 1045.37 1040.36 to 1068.18 -1.18% 0.57 times
01 Mon Dec 2025 1057.89 1055.00 to 1084.15 -1.63% 1.03 times
28 Fri Nov 2025 1075.47 1067.69 to 1099.05 -2.67% 0.92 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared USA

 

Back to top